Friday, May 15, 2020 Researchers Find Robust T Cell Responses in People Who Recovered from COVID-19 Scientists from the La Jolla Institute for Immunology have identified robust T cell responses to SARS-CoV-2, the virus that causes COVID-19, in people who have recovered from the illness. Findings of the NIAID-supported research were published today in Cell. Such T cell responses suggest infection or a vaccine may induce immunity. Researchers also found that blood samples collected from people who were not exposed to SARS-CoV-2 also produce some T cell responses. This observation may be explained by pre-existing immunity to related coronaviruses that cause the common cold. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107